These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations. Al Hadithy AF; de Boer NK; Derijks LJ; Escher JC; Mulder CJ; Brouwers JR Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214 [TBL] [Abstract][Full Text] [Related]
9. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Seidman EG Rev Gastroenterol Disord; 2003; 3 Suppl 1():S30-8. PubMed ID: 12684587 [TBL] [Abstract][Full Text] [Related]
10. Thiopurine therapy: when to start and when to stop. McGovern DP; Travis SP Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):219-23. PubMed ID: 12610314 [TBL] [Abstract][Full Text] [Related]
11. Thiopurine-induced pancreatitis in inflammatory bowel diseases. Ledder O; Lemberg DA; Day AS Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):399-403. PubMed ID: 25494551 [TBL] [Abstract][Full Text] [Related]
12. Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy. Palmieri O; Latiano A; Bossa F; Vecchi M; D'IncĂ R; Guagnozzi D; Tonelli F; Cucchiara S; Valvano MR; Latiano T; Andriulli A; Annese V Aliment Pharmacol Ther; 2007 Sep; 26(5):737-45. PubMed ID: 17697207 [TBL] [Abstract][Full Text] [Related]
13. Thiopurines in Crohn's disease, is there something new? Miheller P; Lakatos PL Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1505-14. PubMed ID: 20919963 [TBL] [Abstract][Full Text] [Related]
14. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease. Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B; Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396 [TBL] [Abstract][Full Text] [Related]
15. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease. Ansari A; Patel N; Sanderson J; O'Donohue J; Duley JA; Florin TH Aliment Pharmacol Ther; 2010 Mar; 31(6):640-7. PubMed ID: 20015102 [TBL] [Abstract][Full Text] [Related]
16. Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use. Min MX; Weinberg DI; McCabe RP J Clin Pharm Ther; 2014 Apr; 39(2):107-11. PubMed ID: 24438369 [TBL] [Abstract][Full Text] [Related]
17. The role of thiopurine metabolite monitoring in inflammatory bowel disease. Beswick L; Friedman AB; Sparrow MP Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):383-92. PubMed ID: 24684593 [TBL] [Abstract][Full Text] [Related]
18. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine. Su C; Lichtenstein GR Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535 [TBL] [Abstract][Full Text] [Related]
19. Thiopurine S-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients. Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Syriopoulou VP; Goutas N; Vlachodimitropoulos D; Anagnou NP; Roma-Giannikou E J Clin Pharm Ther; 2010 Feb; 35(1):93-7. PubMed ID: 20175817 [TBL] [Abstract][Full Text] [Related]
20. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease. Cao Q; Zhu Q; Shang Y; Gao M; Si J Digestion; 2009; 79(1):58-63. PubMed ID: 19252404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]